MaxCyte Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, MaxCyte stock has a consensus rating of "Strong Buy" and an average price target of $4.11. The average 1-year stock price forecast is 209.02% higher than the current stock price, while the lowest is $2.43 (+82.71%) and the highest is $5.00 (+275.94%).

Price Target: $4.11 (+209.02%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$2.43	$4.11	$4.50	$5.00
Change	+82.71%	+209.02%	+238.35%	+275.94%

* Price targets were last updated on May 13, 2026.

Analyst Ratings

The average analyst rating for MaxCyte stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	5	5	5	5	5	5
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt Hewitt Craig-Hallum	Craig-Hallum	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 25, 2026
Daniel Arias Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $4	Buy	Maintains	$4	+200.75%	May 13, 2026
Matt Larew William Blair	William Blair	Hold Maintains n/a	Hold	Maintains	n/a	n/a	May 13, 2026
Mark Massaro BTIG	BTIG	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 13, 2026
Brendan Smith TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

31.08M

from 33.03M

-5.88%

from 33.03M

Revenue Next Year

37.09M

from 31.08M

19.34%

from 31.08M

EPS This Year

-0.27

from -0.36

EPS Next Year

-0.24

from -0.27

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	33.89M	44.26M	41.29M	38.63M	33.03M	31.08M
Revenue Growth	29.52%	30.59%	-6.72%	-6.44%	-14.50%	-5.88%
Gross Profit	30.25M	39.16M	36.55M	31.53M	26.80M	24.27M
Gross Margin	89.24%	88.48%	88.51%	81.62%	81.16%	78.08%
Operating Income	-18.19M	-27.36M	-48.30M	-51.03M	-44.53M	-35.30M
Net Income	-19.08M	-23.57M	-37.92M	-41.06M	-44.63M	-29.44M
EPS	-	-	-	-	-0.36	-0.27
Free Cash Flow	-6.82M	-30.49M	-10.51M	-13.14M	-15.47M	-19.09M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	31.9M
Avg	31.1M
Low	30.5M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-3.5%
Avg	-5.9%
Low	-7.5%

EPS Forecast

EPS	2026	2027	2028
High	-0.26
Avg	-0.27
Low	-0.29

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-